Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b + cell secretion response
Bioengineering & Translational Medicine · 2025-11 · 10 (6)
DOI: 10.1002/btm2.70043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 07.07.2025. Verfasst von Kerwin Kwek Zeming und 8 weiteren Autor:innen. Beteiligte Einrichtung: Critical Analytics for Manufacturing of Personalised Medicine Singapore-MIT Alliance for Research and Technology Singapore Singapore. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation Singapore.
Abstract (Originalsprache)
Acute myocardial infarction (AMI), a leading cause of death globally, triggers complex inflammatory responses critical to patient outcomes. However, rapid tools for profiling immune responses at the single‐cell level are lacking. The integrated Single‐cell Enzyme and Antigen Quantification (iSEAQ) system addresses this gap by enabling high‐throughput, single‐cell analysis of immune cell activity using just 20 μL of blood. This novel tool processes live CD66b and CD3 cells to quantify the secretion of Granzyme B, Neutrophil Elastase, and CD31 within minutes. Longitudinal studies on nine AMI patients revealed that CD66b + cells are major contributors (up to 95%) to key inflammatory enzymes, including the unexpected secretion of Granzyme B. iSEAQ achieves unparalleled sensitivity (0.4 fg/cell) and predictive accuracy (>90%) for patient profiling across AMI onset, treatment, and discharge. This innovation provides clinicians with a rapid, precise method to monitor immune responses, unveiling new insights into AMI inflammation and therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Critical Analytics for Manufacturing of Personalised Medicine Singapore-MIT Alliance for Research and Technology Singapore Singapore.
- Graduate School for Integrative Sciences and Engineering National University of Singapore Singapore Singapore.
- Department of Cardiology National University Heart Centre Singapore Singapore.
- Department of Biomedical Engineering National University of Singapore Singapore Singapore.
- Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology Cambridge Massachusets USA.
- Department of Biological Engineering Massachusetts Institute of Technology Cambridge Massachusets USA.
ORCID-Profile: Kerwin Kwek Zeming, Lih Feng Cheow
Förderung
- National Research Foundation Singapore
Zitieren
APA
Zeming, K. K., Lu, R., Lee, E., Cheung, K. W., Chew, N. W. S., Woo, K. L., Cheow, L. F., Han, J., & Lim, S. L. (2025). Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b + cell secretion response. Bioengineering & Translational Medicine, 10(6). https://doi.org/10.1002/btm2.70043
Vancouver
Zeming KK, Lu R, Lee E, Cheung KW, Chew NWS, Woo KL, et al. Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b + cell secretion response. Bioengineering & Translational Medicine. 2025;10(6). doi:10.1002/btm2.70043
BibTeX
@article{Zeming2025,
author = {Zeming, Kerwin Kwek and Lu, Ri and Lee, Elizabeth and Cheung, Ka-Wai and Chew, Nicholas W S and Woo, Kai Lee and Cheow, Lih Feng and Han, Jongyoon and Lim, Shir Lynn},
title = {Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b + cell secretion response},
journal = {Bioengineering & Translational Medicine},
year = {2025},
volume = {10},
number = {6},
doi = {10.1002/btm2.70043}
}
EUVIMED